ShareSmile Biotech Attends 2024 WDS International Conference

Dr. Chao-Yun Chi of Taichung Veterans General Hospital Presents Clinical Report on OSAWELL® Therapy

In October 2024, ShareSmile Biotech Co., Ltd. was honored to participate in the World Dental Sleep 2024 International Conference (World Dentofacial Sleep Society, WDS 2024) held in San Francisco, USA. The event brought together top experts in dentistry, otolaryngology, and sleep medicine from around the world to exchange insights and explore advancements in interdisciplinary care.

During the conference, Dr. Chao-Yun Chi, Director of the Department of Otolaryngology at Taichung Veterans General Hospital, was invited by the organizers to represent Taiwan with a featured presentation. Dr. Chi shared a clinical case report on the use of the OSAWELL® oral appliance in the treatment of obstructive sleep apnea (OSA).

Drawing from real-world treatment outcomes and improved patient compliance data, Dr. Chi provided an in-depth analysis of OSAWELL®’s clinical value in enhancing comfort, therapeutic effectiveness, and long-term patient management. The presentation sparked significant interest and discussion among international experts, reflecting growing global recognition of oral appliance therapy in OSA care.

ShareSmile Biotech reaffirmed its commitment to positioning Taiwan as a hub for medical innovation, and to partnering with leading global clinicians to advance the digitalization of oral sleep medicine. The company continues to develop smarter, more personalized, and patient-centric solutions to improve sleep health worldwide.

"ShareSmile Biotech — Empowering Global Sleep Wellness Through Innovation and Clinical Excellence."